Search Results - "Boncek, Virginia M."

P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K by BARRETT, David G, BONCEK, Virginia M, PAYNE, J. Alan, RAY, John A, SAMANO, Vicente, SHEWCHUK, Lisa M, TAVARES, Francis X, WELLS-KNECHT, Kevin J, WILLARD, Derril H, WRIGHT, Lois L, ZHOU, Hui-Qiang Q, CATALANO, John G, DEATON, David N, HASSELL, Anne M, JURGENSEN, Cynthia H, LONG, Stacey T, MCFADYEN, Robert B, MILLER, Aaron B, MILLER, Larry R

“…An orally bioavailable series of ketoamide-based cathepsin K inhibitors with good pharmacokinetic properties has been identified. Starting from a potent…”
Get full text

P 2–P 3 conformationally constrained ketoamide-based inhibitors of cathepsin K by Barrett, David G., Boncek, Virginia M., Catalano, John G., Deaton, David N., Hassell, Anne M., Jurgensen, Cynthia H., Long, Stacey T., McFadyen, Robert B., Miller, Aaron B., Miller, Larry R., Payne, J. Alan, Ray, John A., Samano, Vicente, Shewchuk, Lisa M., Tavares, Francis X., Wells-Knecht, Kevin J., Willard, Derril H., Wright, Lois L., Zhou, Hui-Qiang Q.

“…An orally bioavailable series of ketoamide-based cathepsin K inhibitors with good pharmacokinetic properties has been identified. Starting from a potent…”
Get full text

Effects of a small molecule inhibitor of ICAM-1 and E-selectin expression on colonic inflammatory hyperalgesia and colitis by McLean, Peter G., Jurgensen, Cynthia, Boncek, Virginia M., Daluge, Susan M., Sayago, C., Gebhart, G.F., Hicks, Gareth A.

Get full text

1192U90 in animal tests that predict antipsychotic efficacy, anxiolysis, and extrapyramidal side effects by Rigdon, Greg C., Norman, Mark H., Cooper, Barrett R., Howard, James L., Boncek, Virginia M., Faison, Walter L., Nanry, Kevin P., Pollard, Gerald T.

“…1192U90 was developed on the assumption that antagonism of 5-HT2 receptors efficacy yields more potently than D2 receptors against positive and negative…”
Get full text